Nurix Therapeutics, Inc. (NRIX)

NASDAQ: NRIX · Real-Time Price · USD

10.47

-1.41 (-11.87%)

Apr 1, 2025, 4:00 PM EDT - Market closed

Nurix Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is December - November.

Millions USD. Fiscal year is Dec - Nov.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2019 - 2018
Period Ending	Apr '25 Apr 1, 2025	Nov '24 Nov 30, 2024	Nov '23 Nov 30, 2023	Nov '22 Nov 30, 2022	Nov '21 Nov 30, 2021	Nov '20 Nov 30, 2020	2019 - 2018
Market Capitalization	795	1,566	302	584	1,286	1,656	Upgrade
Market Cap Growth	419.13%	419.13%	-48.35%	-54.57%	-22.36%	-	Upgrade
Enterprise Value	212	1,136	41	184	942	1,302	Upgrade
Last Close Price	11.88	22.11	6.22	12.39	28.82	42.62	Upgrade
PS Ratio	14.62	28.71	3.92	15.12	43.22	92.93	Upgrade
PB Ratio	1.71	2.97	1.51	1.92	3.76	5.71	Upgrade
P/TBV Ratio	2.97	2.97	1.51	1.92	3.76	5.71	Upgrade
EV/Sales Ratio	3.89	20.82	0.53	4.76	31.66	73.05	Upgrade
Debt / Equity Ratio	0.05	0.05	0.15	0.04	0.04	-	Upgrade
Asset Turnover	0.11	0.11	0.20	0.09	0.07	0.08	Upgrade
Quick Ratio	6.38	6.38	3.32	4.39	4.57	6.58	Upgrade
Current Ratio	6.46	6.46	3.40	4.51	4.70	6.70	Upgrade
Return on Equity (ROE)	-53.22%	-53.22%	-57.10%	-55.84%	-37.05%	-30.80%	Upgrade
Return on Assets (ROA)	-25.98%	-25.98%	-25.10%	-25.72%	-16.88%	-18.45%	Upgrade
Return on Capital (ROIC)	-33.86%	-33.86%	-35.45%	-34.25%	-22.82%	-28.93%	Upgrade
Earnings Yield	-24.40%	-12.36%	-47.71%	-30.88%	-9.12%	-2.61%	Upgrade
FCF Yield	-22.92%	-11.61%	-29.75%	-29.45%	-7.00%	-0.28%	Upgrade
Buyback Yield / Dilution	-23.52%	-23.52%	-11.79%	-13.32%	-173.68%	-376.03%	Upgrade

Updated Jan 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q